Testing Nivolumab to Prevent Disease From Coming Back After Treatment in Patients With Acute Myeloid Leukemia, REMAIN Trial
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Mayo Clinic
Beth Israel Deaconess Medical Center
Sellas Life Sciences Group
Eastern Cooperative Oncology Group
University of Giessen
National Cancer Institute (NCI)
Novartis
SWOG Cancer Research Network
Children's Oncology Group
University of Minnesota
National Cancer Institute (NCI)